NO874796L - Hybridomcellelinjer som produserer monoklonale antistoffer som reagerer med mucinepitoper. - Google Patents
Hybridomcellelinjer som produserer monoklonale antistoffer som reagerer med mucinepitoper.Info
- Publication number
- NO874796L NO874796L NO87874796A NO874796A NO874796L NO 874796 L NO874796 L NO 874796L NO 87874796 A NO87874796 A NO 87874796A NO 874796 A NO874796 A NO 874796A NO 874796 L NO874796 L NO 874796L
- Authority
- NO
- Norway
- Prior art keywords
- cell lines
- monoclonal antibodies
- producing monoclonal
- pitopes
- hybridom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3023—Lung
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93278186A | 1986-11-19 | 1986-11-19 | |
US10451187A | 1987-10-08 | 1987-10-08 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO874796D0 NO874796D0 (no) | 1987-11-18 |
NO874796L true NO874796L (no) | 1988-05-20 |
NO175944B NO175944B (no) | 1994-09-26 |
NO175944C NO175944C (no) | 1995-01-04 |
Family
ID=26801637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO874796A NO175944C (no) | 1986-11-19 | 1987-11-18 | Monoklonale antistoffer for anvendelse til in vitro påvisning av tumorassosiert mucinantigen, og hybridomcellelinjer som produserer disse |
Country Status (17)
Country | Link |
---|---|
US (1) | US5849876A (no) |
EP (1) | EP0268279B2 (no) |
JP (1) | JP2597372B2 (no) |
KR (1) | KR900007951B1 (no) |
AT (1) | ATE130029T1 (no) |
AU (1) | AU613590B2 (no) |
CA (1) | CA1340815C (no) |
DE (1) | DE3751585T3 (no) |
DK (1) | DK175635B1 (no) |
ES (1) | ES2080717T5 (no) |
GR (1) | GR3018093T3 (no) |
HK (1) | HK1007766A1 (no) |
IE (1) | IE71154B1 (no) |
IL (1) | IL84475A (no) |
NO (1) | NO175944C (no) |
NZ (1) | NZ222509A (no) |
PT (1) | PT86180B (no) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6222020B1 (en) * | 1987-01-07 | 2001-04-24 | Imperial Cancer Research Technology Limited | Antigens derived from the core protein of the human mammary epithelial mucin |
AU625856B2 (en) * | 1987-07-15 | 1992-07-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
JPH02255097A (ja) * | 1989-03-29 | 1990-10-15 | Ikuo Yamashina | 単クローン抗体nny128 |
JPH06503177A (ja) * | 1991-06-26 | 1994-04-07 | ザ バイオメンブレイン インスティテュート | 抗―炭水化物抗体の組合せを利用しての肺癌の早期診断 |
FR2697088B1 (fr) * | 1992-10-15 | 1997-06-27 | Lacassagne Centre Antoine | Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic. |
EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
US6207805B1 (en) * | 1997-07-18 | 2001-03-27 | University Of Iowa Research Foundation | Prostate cell surface antigen-specific antibodies |
JP2002518347A (ja) | 1998-06-15 | 2002-06-25 | アルタレックス コーポレイション | 前立腺癌治療のための免疫療法組成物および方法 |
US8071072B2 (en) * | 1999-10-08 | 2011-12-06 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7442776B2 (en) * | 1999-10-08 | 2008-10-28 | Young David S F | Cancerous disease modifying antibodies |
US20080124327A1 (en) * | 1999-10-08 | 2008-05-29 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20050100542A1 (en) * | 1999-10-08 | 2005-05-12 | Young David S. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US6794494B1 (en) | 2003-04-14 | 2004-09-21 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7947496B2 (en) | 1999-10-08 | 2011-05-24 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20090004103A1 (en) * | 1999-10-08 | 2009-01-01 | Young David S F | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US6657048B2 (en) * | 1999-10-08 | 2003-12-02 | Arius Research, Inc. | Individualized anti-cancer antibodies |
US7252821B2 (en) | 1999-10-08 | 2007-08-07 | Arius Research Inc. | Cancerous disease modifying antibodies |
US20040001789A1 (en) * | 1999-10-08 | 2004-01-01 | Young David S. F. | Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof |
US20040105816A1 (en) * | 1999-10-08 | 2004-06-03 | Young David S. F. | Cancerous disease modifying antibodies |
US7256271B2 (en) | 2003-01-21 | 2007-08-14 | Arius Research Inc. | Cancerous disease modifying antibodies |
US8048416B2 (en) * | 1999-10-08 | 2011-11-01 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7189397B2 (en) * | 1999-10-08 | 2007-03-13 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7419792B2 (en) * | 1999-10-08 | 2008-09-02 | Arius Research Inc. | Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody |
US6180357B1 (en) * | 1999-10-08 | 2001-01-30 | Arius Research, Inc. | Individualized patient-specific anti-cancer antibodies |
MXPA02010869A (es) * | 2000-05-08 | 2003-04-14 | Medarex Inc | Anticuerpos monoclonales humanos para celulas dendriticas. |
US7534429B2 (en) * | 2000-11-29 | 2009-05-19 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
US20060210474A1 (en) * | 2000-11-29 | 2006-09-21 | Young David S | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
US7009040B2 (en) * | 2003-01-21 | 2006-03-07 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7442777B2 (en) * | 2000-11-29 | 2008-10-28 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
US7361343B2 (en) * | 2003-01-21 | 2008-04-22 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
US7431923B2 (en) * | 2005-01-03 | 2008-10-07 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
EP2287198A3 (en) | 2002-03-13 | 2011-05-25 | Biogen Idec MA Inc. | Anti-alpha V beta 6 antibodies |
AU2003295502A1 (en) | 2002-11-12 | 2004-06-03 | Yucheng Chang | Adenoviral vector vaccine |
US7361342B2 (en) * | 2003-01-21 | 2008-04-22 | Arius Research Inc. | Cancerous disease modifying antibodies |
US7393531B2 (en) | 2003-01-21 | 2008-07-01 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
US7488475B2 (en) | 2003-01-21 | 2009-02-10 | Arius Research, Inc. | Antibody therapy of tumors |
US7175846B2 (en) * | 2003-01-21 | 2007-02-13 | Arius Research Inc. | Cancerous disease modifying antibodies |
US7468254B2 (en) * | 2003-01-21 | 2008-12-23 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of MCSP |
US20060140963A1 (en) * | 2003-04-14 | 2006-06-29 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD59 |
US20080025977A1 (en) * | 2003-04-14 | 2008-01-31 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD59 |
US20080213169A1 (en) * | 2003-04-14 | 2008-09-04 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD59 |
US7195764B2 (en) | 2003-04-14 | 2007-03-27 | Arius Research Inc. | Cancerous disease modifying antibodies |
US7399835B2 (en) * | 2004-02-26 | 2008-07-15 | Arius Research Inc. | Cancerous disease modifying antibodies |
US20050027106A1 (en) * | 2003-07-28 | 2005-02-03 | Young David S. F. | Cancerous disease modifying antibodies |
EP1687334B1 (en) | 2003-11-24 | 2014-01-08 | MicroVAX, LLC | Mucin antigen vaccine |
US8828957B2 (en) * | 2003-12-11 | 2014-09-09 | Microvax, Llc | Methods for generating immunity to antigen |
US7348413B2 (en) * | 2004-02-26 | 2008-03-25 | Arius Research Inc. | Cancerous disease modifying antibodies |
US20050255041A1 (en) * | 2004-05-13 | 2005-11-17 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7394210B2 (en) * | 2004-09-29 | 2008-07-01 | Tir Technology Lp | System and method for controlling luminaires |
WO2006130525A2 (en) * | 2005-05-31 | 2006-12-07 | Sidney Kimmel Cancer Center | Methods for immunotherapy of cancer |
US7452978B2 (en) * | 2005-08-02 | 2008-11-18 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7411046B2 (en) | 2005-08-02 | 2008-08-12 | Arius Research Inc | Cancerous disease modifying antibodies |
US7494648B2 (en) * | 2005-08-02 | 2009-02-24 | Hoffmann-La Roche Inc. | Cancerous disease modifying antibodies |
US7456259B2 (en) | 2005-08-02 | 2008-11-25 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7452979B2 (en) | 2005-08-02 | 2008-11-18 | Arius Research, Inc. | Cancerous disease modifying antibodies |
US7456258B2 (en) | 2005-08-02 | 2008-11-25 | Arius Research, Inc. | Cancerous disease modifying antibodies |
CA2628837C (en) * | 2005-11-07 | 2018-11-27 | Sidney Kimmel Cancer Center | Cd40 ligand fusion protein vaccine |
US7420041B2 (en) * | 2006-02-24 | 2008-09-02 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
US20080305104A1 (en) * | 2006-02-24 | 2008-12-11 | Young David S F | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
CN101675158A (zh) * | 2006-02-24 | 2010-03-17 | 阿里乌斯研究公司 | 癌性疾病调节抗体 |
US20080213267A1 (en) * | 2006-02-24 | 2008-09-04 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
WO2007095745A1 (en) | 2006-02-24 | 2007-08-30 | Arius Research Inc. | Cancerous disease modifying antibody 141205-02 |
US20080089891A1 (en) * | 2006-07-26 | 2008-04-17 | Arius Research, Inc. | Cancerous disease modifying antibodies |
KR20090059166A (ko) * | 2006-09-28 | 2009-06-10 | 센토코 오르토 바이오테크 인코포레이티드 | 단일클론 항체 생산에서 애주번트로서의 프로스타글란딘 e2 (pge2) |
CN101535471B (zh) * | 2006-11-13 | 2011-06-29 | 霍夫曼-拉罗奇有限公司 | 修饰癌症病的抗体180706-02 |
KR20090088879A (ko) * | 2006-11-13 | 2009-08-20 | 에프. 호프만-라 로슈 아게 | 암 질환 조절 항체 |
WO2008058381A1 (en) * | 2006-11-13 | 2008-05-22 | Arius Research Inc. | Cancerous disease modifying antibodies |
US8003761B2 (en) | 2007-01-23 | 2011-08-23 | Hoffmann-La Roche Inc. | Cancerous disease modifying antibodies |
US20080206133A1 (en) * | 2007-01-23 | 2008-08-28 | Young David S F | Cancerous Disease Modifying Antibodies |
KR20090114454A (ko) * | 2007-03-26 | 2009-11-03 | 에프. 호프만-라 로슈 아게 | 하이브리도마 세포주 ar51a630.3 에 의해 생성된 암 질환 조절 항체 010207-01. |
CN101688183A (zh) * | 2007-05-07 | 2010-03-31 | 霍夫曼-拉罗奇有限公司 | 减轻癌性疾病的抗体 |
US20090191197A1 (en) * | 2008-01-28 | 2009-07-30 | Young David S F | Cancerous disease modifying antibodies |
WO2009124381A1 (en) * | 2008-04-10 | 2009-10-15 | F. Hoffmann-La Roche Ag | An anti-cancer cytotoxic monoclonal antibody |
JP2011520923A (ja) * | 2008-05-19 | 2011-07-21 | 武田薬品工業株式会社 | 細胞傷害性抗癌モノクローナル抗体 |
EP2313437A1 (en) * | 2008-07-17 | 2011-04-27 | Takeda Pharmaceutical Company Limited | Cancerous disease modifying antibodies |
WO2011004899A1 (en) | 2009-07-06 | 2011-01-13 | Takeda Pharmaceutical Company Limited | Cancerous disease modifying antibodies |
US10035860B2 (en) | 2013-03-15 | 2018-07-31 | Biogen Ma Inc. | Anti-alpha V beta 6 antibodies and uses thereof |
US10035859B2 (en) | 2013-03-15 | 2018-07-31 | Biogen Ma Inc. | Anti-alpha V beta 6 antibodies and uses thereof |
EP3397592B1 (en) * | 2015-12-30 | 2022-11-09 | Colgate-Palmolive Company | Mucin coated silica for bacterial aggregation |
CN110317273A (zh) * | 2018-03-30 | 2019-10-11 | 积水医疗株式会社 | 与dupan-2抗原特异性反应的单克隆抗体及其制造方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4650756A (en) * | 1981-08-31 | 1987-03-17 | Sloan Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human renal cancer |
US4584268A (en) * | 1981-10-13 | 1986-04-22 | Ceriani Roberto Luis | Method and compositions for carcinoma diagnosis |
US4522918A (en) * | 1981-12-15 | 1985-06-11 | Jeffery Schlom | Process for producing monoclonal antibodies reactive with human breast cancer |
US4612282A (en) * | 1981-12-15 | 1986-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Monoclonal antibodies reactive with human breast cancer |
US4485093A (en) * | 1982-08-13 | 1984-11-27 | Runge Richard G | Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer |
GB2131830A (en) * | 1982-12-10 | 1984-06-27 | Ludwig Inst Cancer Res | Monoclonal antibody for use against breast cancer |
US4678747A (en) * | 1983-02-18 | 1987-07-07 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies for detection of an H (O) blood group antigen |
US4916213A (en) * | 1983-02-22 | 1990-04-10 | Xoma Corporation | Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof |
DE3483054D1 (de) * | 1983-03-04 | 1990-10-04 | Health Research Inc | Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie. |
US4643971A (en) * | 1983-03-11 | 1987-02-17 | Sloan-Kettering Institute | Monoclonal antibodies to human bladder and ureter cancers and method |
WO1985002411A1 (en) * | 1983-11-25 | 1985-06-06 | The University Of Melbourne | Cell line and monoclonal antibody |
US4753894A (en) * | 1984-02-08 | 1988-06-28 | Cetus Corporation | Monoclonal anti-human breast cancer antibodies |
US4935344A (en) * | 1984-04-30 | 1990-06-19 | Sloan-Kettering Institute For Cancer Research | Method for characterizing types of renal carcinoma and prognosis |
EP0160446B1 (en) * | 1984-05-01 | 1992-06-17 | Ciba Corning Diagnostics Corp. | Breast tumor-associated antigen and monoclonal antibodies specific thereto |
US4960716A (en) * | 1984-05-01 | 1990-10-02 | Ciba Corning Diagnostics Corp. | Monoclonal antibodies specific for 330 KD breast tumor antigen and assay using said monoclonal antibodies |
US4683200A (en) * | 1984-05-17 | 1987-07-28 | Setsuo Hirohashi | Monoclonal antibody to human cancer antigen and method for producing same |
US4752569A (en) * | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
NZ212419A (en) * | 1984-06-25 | 1988-08-30 | Mucan Diagnostics Pty Ltd | In vitro diagnostic test for detecting cancer cells producing mucin antigens |
US4707438A (en) * | 1984-08-22 | 1987-11-17 | Tel Aviv University | Immunoassay for breast cancer employing monoclonal antibodies |
IL76877A (en) * | 1984-11-02 | 1991-11-21 | Oncogen | Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies |
US4628032A (en) * | 1984-12-05 | 1986-12-09 | The Salk Institute For Biological Studies | Monoclonal antibody specific for a mammary tumor cytoplasmic antigen |
EP0184369B1 (en) * | 1984-12-05 | 1992-04-01 | The Salk Institute For Biological Studies | Monoclonal antibody specific for a mammary tumor cell surface antigen |
ES8800604A1 (es) * | 1985-04-22 | 1987-11-16 | Hybritech Inc | Un metodo para producir anticuerpos monoclonales |
US4814275A (en) * | 1985-05-13 | 1989-03-21 | E.I. Dupont De Nemours And Company | Monoclonal hybridoma antibody specific for a human epithelial antigen |
US4863854A (en) * | 1985-08-12 | 1989-09-05 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to mucin-like human differentiation antigens |
US4938948A (en) * | 1985-10-07 | 1990-07-03 | Cetus Corporation | Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies |
US4803169A (en) † | 1986-02-05 | 1989-02-07 | Cetus Corporation | Assay for human breast cancer |
WO1988005054A1 (en) † | 1987-01-07 | 1988-07-14 | Imperial Cancer Research Technology Limited | Probe |
-
1987
- 1987-11-11 AU AU80994/87A patent/AU613590B2/en not_active Ceased
- 1987-11-11 NZ NZ222509A patent/NZ222509A/en unknown
- 1987-11-16 IL IL84475A patent/IL84475A/xx not_active IP Right Cessation
- 1987-11-16 CA CA000551952A patent/CA1340815C/en not_active Expired - Fee Related
- 1987-11-17 AT AT87116997T patent/ATE130029T1/de not_active IP Right Cessation
- 1987-11-17 DE DE3751585T patent/DE3751585T3/de not_active Expired - Lifetime
- 1987-11-17 EP EP87116997A patent/EP0268279B2/en not_active Expired - Lifetime
- 1987-11-17 ES ES87116997T patent/ES2080717T5/es not_active Expired - Lifetime
- 1987-11-18 IE IE311087A patent/IE71154B1/en not_active IP Right Cessation
- 1987-11-18 JP JP62291645A patent/JP2597372B2/ja not_active Expired - Lifetime
- 1987-11-18 KR KR1019870012996A patent/KR900007951B1/ko not_active IP Right Cessation
- 1987-11-18 NO NO874796A patent/NO175944C/no not_active IP Right Cessation
- 1987-11-18 DK DK198706062A patent/DK175635B1/da not_active IP Right Cessation
- 1987-11-19 PT PT86180A patent/PT86180B/pt unknown
-
1994
- 1994-01-11 US US08/179,875 patent/US5849876A/en not_active Expired - Fee Related
-
1995
- 1995-11-15 GR GR950403215T patent/GR3018093T3/el unknown
-
1998
- 1998-06-26 HK HK98106951A patent/HK1007766A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL84475A (en) | 1992-06-21 |
EP0268279B2 (en) | 2003-12-03 |
KR900007951B1 (ko) | 1990-10-23 |
CA1340815C (en) | 1999-11-09 |
NO175944C (no) | 1995-01-04 |
EP0268279A2 (en) | 1988-05-25 |
EP0268279B1 (en) | 1995-11-08 |
NO175944B (no) | 1994-09-26 |
JP2597372B2 (ja) | 1997-04-02 |
GR3018093T3 (en) | 1996-02-29 |
AU8099487A (en) | 1988-06-09 |
IE71154B1 (en) | 1997-01-29 |
ES2080717T5 (es) | 2004-07-16 |
KR880006358A (ko) | 1988-07-22 |
IE873110L (en) | 1988-05-19 |
DE3751585T2 (de) | 1996-04-25 |
US5849876A (en) | 1998-12-15 |
PT86180A (en) | 1987-12-01 |
DK606287D0 (da) | 1987-11-18 |
DE3751585T3 (de) | 2004-08-05 |
ATE130029T1 (de) | 1995-11-15 |
DK606287A (da) | 1988-05-20 |
EP0268279A3 (en) | 1991-07-03 |
NZ222509A (en) | 1993-03-26 |
AU613590B2 (en) | 1991-08-08 |
HK1007766A1 (en) | 1999-04-23 |
IL84475A0 (en) | 1988-04-29 |
DK175635B1 (da) | 2004-12-27 |
JPS63279784A (ja) | 1988-11-16 |
DE3751585D1 (de) | 1995-12-14 |
ES2080717T3 (es) | 1996-02-16 |
PT86180B (pt) | 1990-11-07 |
NO874796D0 (no) | 1987-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO874796L (no) | Hybridomcellelinjer som produserer monoklonale antistoffer som reagerer med mucinepitoper. | |
PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
EP0118365A3 (en) | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy | |
ES8609731A1 (es) | Un metodo para diagnosticar una condicion neoplastica en un hospedante mamifero | |
ZA833686B (en) | Human human hybridomas for cervical carcinoma | |
NZ210867A (en) | Tumour-specific monoclonal antibodies, production thereof and use | |
DK0759032T3 (da) | Isolerede peptider, der er afledt fra MAGE-3, og som komplekserer med HLA-A2-molekyler, samt anvendelse heraf | |
GB2182949A (en) | Monoclonal antibodies and antigens for human non-small cell lung carcinomas | |
EP0232871A3 (en) | Human monoclonal antibody, hybridoma producing the same and its use | |
DK0454782T3 (da) | Cancer-beslægtet haptaglobin (Hpr.) | |
ES8800604A1 (es) | Un metodo para producir anticuerpos monoclonales | |
EP0297930A3 (en) | Monoclonal antibodies | |
DE59209776D1 (de) | Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstellung und ihre Verwendung | |
EP0166458A3 (en) | Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells | |
EP0278160A3 (en) | Human monoclonal anti cancer antibodies, hybridoma cell lines producing them and their uses | |
GR3007245T3 (no) | ||
EP0243058A3 (en) | A novel tumor associated antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |